01 6Gilead Sciences Canada Inc.
02 5GlaxoSmithKline Inc.
01 22398887
02 12416757
03 22452217
04 12537095
05 22577288
06 12606282
07 12787691
08 12845553
01 5DOLUTEGRAVIR SODIUM | RILPIVIRINE HYDROCHLORIDE
02 6EMTRICITABINE | RILPIVIRINE HYDROCHLORIDE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
01 11TABLET
01 22021-02-26
02 12021-07-20
03 22022-08-09
04 12024-09-03
05 22025-09-02
06 12026-04-28
07 12031-01-24
08 12032-08-15
Patent Expiration Date : 2025-09-02
Date Granted : 2010-11-30
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : ODEFSEY
Patent Number : 2577288
Filing Date : 2005-09-02
Strength per Unit : 200 mg / 25 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-09-02
Date Granted : 2010-11-30
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-09-03
Date Granted : 2012-05-29
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : ODEFSEY
Patent Number : 2537095
Filing Date : 2004-09-03
Strength per Unit : 200 mg / 25 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-09-03
Date Granted : 2012-05-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : ODEFSEY
Patent Number : 2452217
Filing Date : 2002-08-09
Strength per Unit : 200 mg / 25 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : ODEFSEY
Patent Number : 2416757
Filing Date : 2001-07-20
Strength per Unit : 200 mg / 25 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : ODEFSEY
Patent Number : 2398887
Filing Date : 2001-02-26
Strength per Unit : 200 mg / 25 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-08-15
Date Granted : 2019-05-28
EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : ODEFSEY
Patent Number : 2845553
Filing Date : 2012-08-15
Strength per Unit : 200 mg / 25 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-08-15
Date Granted : 2019-05-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
DOLUTEGRAVIR SODIUM, RILPIVIRINE HYDROCHLORIDE
Brand Name : JULUCA
Patent Number : 2398887
Filing Date : 2001-02-26
Strength per Unit : 50 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
DOLUTEGRAVIR SODIUM, RILPIVIRINE HYDROCHLORIDE
Brand Name : JULUCA
Patent Number : 2452217
Filing Date : 2002-08-09
Strength per Unit : 50 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-08-09
Date Granted : 2009-06-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2025-09-02
Date Granted : 2010-11-30
DOLUTEGRAVIR SODIUM, RILPIVIRINE HYDROCHLORIDE
Brand Name : JULUCA
Patent Number : 2577288
Filing Date : 2005-09-02
Strength per Unit : 50 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-09-02
Date Granted : 2010-11-30
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
DOLUTEGRAVIR SODIUM, RILPIVIRINE HYDROCHLORIDE
Brand Name : JULUCA
Patent Number : 2606282
Filing Date : 2006-04-28
Strength per Unit : 50 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
